华润医药(03320.HK)附属博雅生物提减值 料全年净利大减

阿斯达克财经
Feb 01

华润医药(03320.HK) 公布,附属博雅生物(300294.SZ) 预计,2025年度净利润介乎1.05亿至1.37亿人民币,相较上年度录得3.97亿人民币。主要由于安徽格林克医药分销的医美产品透明质酸市况有所下滑,导致产生无形资产(专营权)减值及商誉减值共约3亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-01-30 16:25。) (A股报价延迟最少十五分钟。)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10